Omeprazole
NDC 83324-141, Omeprazole, tablet, delayed release, from Chain Drug Marketing Association INC.
- Product NDC
- 83324-141
- Status
- Listed
- Labeler
- Chain Drug Marketing Association INC
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA207740
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83324-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OMEPRAZOLE20 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83324-141-14 | 83324014114 | 1 BOTTLE in 1 CARTON (83324-141-14) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE |
| 83324-141-42 | 83324014142 | 3 BOTTLE in 1 CARTON (83324-141-42) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83324-141 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83324-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83324-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.